Codes & Guidelines


PhRMA represents the nation’s leading biopharmaceutical research companies. Our success in developing and delivering medicines to help patients live longer and healthier lives depends on ethical relationships and behavior. Browse key Codes and Guidelines below, and visit our 
Resource Library for more.

Ethical relationships with healthcare professionals are critical to our mission of helping patients by developing and marketing new medicines.

-

CODES & GUIDELINES
In October 2018, PhRMA’s Board of Directors adopted measures to enhance the PhRMA Guiding Principles on Direct to Consumer Advertisements about Prescription Medicines.

-

CODES & GUIDELINES

In the era of data-driven medicine, where all parties seek more, not less, information about the safety, effectiveness, and value of treatments, fostering informed communications among all stakeholders is critical.

-

CODES & GUIDELINES
We need a balanced approach that ensures appropriate access and use of prescription medicines by patients for legitimate medical needs under the direction and care of a licensed health care professional, but that also reduces the potential for misuse, abuse and diversion.

-

CODES & GUIDELINES
Biopharmaceutical companies share many common interests with patient organizations including a common commitment to patients and a shared mission to discover cures and fight disease.

-

CODES & GUIDELINES
Developing new therapies to treat disease and to improve quality of life is a long and complex process. A critical part of that process is clinical research, the study of a pharmaceutical product in humans.

-

Codes & Guidelines

Emerging payment and delivery reforms (often called “alternative payment models” or “value-based payment” designs) hold promise in advancing the efficient delivery of high-quality, personalized care.

-

Codes & Guidelines
Biopharmaceutical companies are committed to enhancing public health through responsible sharing of clinical trial data.

-

CODES & GUIDELINES

In July 2013, members of PhRMA and the European Federation of Pharmaceutical Industries and Associations (EFPIA) adopted Principles for Responsible Clinical Trial Data Sharing.

-

Codes & Guidelines

Healthcare providers and payers are increasingly turning to clinical pathways as tools to manage the cost of care and promote evidence-based treatment.

-

CODES & GUIDELINES
PhRMA supports the use of sound evidence for informed decision-making in health care.

-

Codes & Guidelines